Trilegal advises Iswarya Health on securing ₹355 crore investment from OrbiMed

Iswarya Health Private Limited has secured a primary investment of ₹355 crore from OrbiMed Asia VI Mauritius Limited, an investment vehicle of OrbiMed. Trilegal advised Iswarya Health, and its promoters, Dr. Arun Muthuvel, Dr. S.

Sources

• Bar & Bench - Dealstreet
• BSE corporate announcements · official
• NSE corporate announcements · official

Related deals

• Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
• Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
• Fortis Healthcare Limited: Acquisition28 Oct 2026
• ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
• Trilegal acts on Fusion CX ₹702 crore IPO26 Oct 2026 · ₹702 cr
• Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026